We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
–
AUM
$1.01B
AUM Growth
+$10.8M
Cap. Flow
+$15.1M
Cap. Flow %
1.49%
Top 10 Hldgs %
48.48%
Holding
1,105
New
34
Increased
127
Reduced
181
Closed
47

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$7.12M
2
AMZN icon
Amazon
AMZN
+$4.65M
3
DIS icon
Walt Disney
DIS
+$4.24M
4
CYBR
CyberArk
CYBR
+$3.46M
5
MSFT icon
Microsoft
MSFT
+$2.89M

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$3.89M
2
OLED icon
Universal Display
OLED
+$3.01M
3
MRSH
Marsh
MRSH
+$873K
4
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$809K
5
T icon
AT&T
T
+$797K

Sector Composition

Rank Sector Weight
1 Financials 24.48%
2 Technology 19.26%
3 Consumer Discretionary 16.1%
4 Communication Services 11.75%
5 Healthcare 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRQ
1026
DELISTED
Turquoise Hill Resources Ltd
TRQ
$190 ﹤0.01%
40
– –
TWI icon
1027
Titan International
TWI
$453M
$165 ﹤0.01%
61
– –
GALT icon
1028
Galectin Therapeutics
GALT
$405M
$147 ﹤0.01%
40
– –
FRO icon
1029
Frontline
FRO
$9.84B
$127 ﹤0.01%
14
– –
XBIO icon
1030
Xenetic Biosciences
XBIO
$9.33M
$127 ﹤0.01%
11
– –
KZIA
1031
Kazia Therapeutics
KZIA
$155M
$120 ﹤0.01%
1
– –
MNK
1032
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$89 ﹤0.01%
37
– –
QCLS
1033
Q/C Technologies Inc
QCLS
$19.2M
– –
0
– –
GCVRZ
1034
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$73 ﹤0.01%
130
– –
FAZ
1035
Direxion Daily Financial Bear 3x ETF
FAZ
$88.2M
– –
0
– –
ELOX
1036
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
– –
0
– –
CRIS icon
1037
Curis
CRIS
$3.61M
– –
0
– –
GRCE
1038
Grace Therapeutics
GRCE
$44.6M
$57 ﹤0.01%
1
– –
CRC
1039
DELISTED
California Resources Corporation
CRC
$51 ﹤0.01%
5
– –
SCPX
1040
DELISTED
Scorpius Holdings, Inc.
SCPX
– –
0
– –
TPST icon
1041
Tempest Therapeutics
TPST
$17.5M
– –
0
– –
FCSC
1042
DELISTED
Fibrocell Science Inc.
FCSC
$41 ﹤0.01%
14
– –
GTE icon
1043
Gran Tierra Energy
GTE
$349M
$38 ﹤0.01%
3
– –
GENE
1044
DELISTED
Genetic Technologies Ltd.
GENE
$38 ﹤0.01%
4
– –
BLRX
1045
BioLineRX
BLRX
$11.4M
– –
0
– –
LSTA icon
1046
Lisata Therapeutics
LSTA
$15.2M
$26 ﹤0.01%
1
– –
SDRL
1047
DELISTED
Seadrill Limited Common Stock
SDRL
$19 ﹤0.01%
9
– –
NNVC icon
1048
NanoViricides
NNVC
$31.7M
$14 ﹤0.01%
7
– –
OPTT icon
1049
Ocean Power Technologies
OPTT
$46.2M
$13 ﹤0.01%
7
– –
SNOA icon
1050
Sonoma Pharmaceuticals
SNOA
$6.27M
– –
0
– –
40 41
42
43 44

Similar funds

AP
Advisor Partners Walnut Creek, California $1.42B AUM 3.97% 1-Year Est. Return
AWM
Altium Wealth Management Purchase, New York $1.39B AUM 12.44% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
BRWM
B. Riley Wealth Management Memphis, Tennessee $962M AUM 8.45% 1-Year Est. Return
BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
DHFB
Dixon Hubard Feinour & Brown Roanoke, Virginia $842M AUM 2.74% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return

RBC Europe's Q3 2019 Portfolio in Review

As of Q3 2019, RBC Europe held 1,105 positions worth $1.01B, up 1.1% from $1B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

RBC Europe's Q3 2019 filing shows 34 new, 127 increased, 181 reduced and 47 closed positions. Its largest new stake was Endava: 48,000 shares worth $1.82M. The largest sale was KLA, an estimated $3.89M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

  • RBC Europe's largest Q3 2019 buy was Endava: 48,000 shares worth $1.82M.
  • RBC Europe added most to Berkshire Hathaway Class B in Q3 2019, an estimated $7.12M increase.
  • RBC Europe's biggest Q3 2019 reduction was KLA, cutting an estimated $3.89M.
  • RBC Europe fully exited iShares MSCI Saudi Arabia ETF in Q3 2019, selling an estimated $809K.
  • RBC Europe's ten largest holdings make up 48% of its $1.01B portfolio in Q3 2019.
  • RBC Europe opened 34 new positions and closed 47 in Q3 2019.
  • RBC Europe's portfolio value rose 1.1% quarter-over-quarter to $1.01B.

Based on RBC Europe's 13F filing for Q3 2019, filed 9 Nov 2023.